Sanofi Adr Stock One Year High
SNY Stock | USD 46.61 1.08 2.26% |
Sanofi ADR fundamentals help investors to digest information that contributes to Sanofi ADR's financial success or failures. It also enables traders to predict the movement of Sanofi Stock. The fundamental analysis module provides a way to measure Sanofi ADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sanofi ADR stock.
Sanofi | One Year High |
Sanofi ADR Company One Year High Analysis
Sanofi ADR's One Year High typically refers to the highest price that a given equity instrument has reached in the last 52 weeks. In other words, it is the highest price that investors paid or were willing to pay for a given stock, fund, or ETF over the past 52 weeks of trading.
Sanofi One Year High Driver Correlations
Understanding the fundamental principles of building solid financial models for Sanofi ADR is extremely important. It helps to project a fair market value of Sanofi Stock properly, considering its historical fundamentals such as One Year High. Since Sanofi ADR's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sanofi ADR's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sanofi ADR's interrelated accounts and indicators.
Click cells to compare fundamentals
Year High value is used as an indicator to give investors an idea of how given equity may perform over mid or longer-term horizons. The One Year High may be utilized as a naive indicator of how the value of a stock is resistant or elastic over the long term investment horizon. For example, if the price of a fund or ETF is near a new One Year High, a rational investor may interpret it as a turning point and trade the instrument away or buy additional shares.
Competition |
Based on the recorded statements, Sanofi ADR has an One Year High of 0.0. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Sanofi One Year High Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sanofi ADR's direct or indirect competition against its One Year High to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sanofi ADR could also be used in its relative valuation, which is a method of valuing Sanofi ADR by comparing valuation metrics of similar companies.Sanofi ADR is currently under evaluation in one year high category among related companies.
Sanofi ADR Current Valuation Drivers
We derive many important indicators used in calculating different scores of Sanofi ADR from analyzing Sanofi ADR's financial statements. These drivers represent accounts that assess Sanofi ADR's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Sanofi ADR's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 112.0B | 98.7B | 110.9B | 112.5B | 101.2B | 67.8B | |
Enterprise Value | 128.5B | 108.4B | 123.3B | 120.9B | 108.9B | 73.8B |
Sanofi Fundamentals
Return On Equity | 0.0727 | ||||
Return On Asset | 0.0454 | ||||
Profit Margin | 0.12 % | ||||
Operating Margin | 0.07 % | ||||
Current Valuation | 69.57 B | ||||
Shares Outstanding | 2.5 B | ||||
Shares Owned By Institutions | 9.95 % | ||||
Number Of Shares Shorted | 3.9 M | ||||
Price To Earning | 7.78 X | ||||
Price To Book | 1.44 X | ||||
Price To Sales | 2.52 X | ||||
Revenue | 43.07 B | ||||
Gross Profit | 31.7 B | ||||
EBITDA | 12.96 B | ||||
Net Income | 5.4 B | ||||
Cash And Equivalents | 6.9 B | ||||
Cash Per Share | 2.76 X | ||||
Total Debt | 18.42 B | ||||
Debt To Equity | 0.30 % | ||||
Current Ratio | 1.30 X | ||||
Book Value Per Share | 59.17 X | ||||
Cash Flow From Operations | 10.26 B | ||||
Short Ratio | 2.34 X | ||||
Earnings Per Share | 2.29 X | ||||
Price To Earnings To Growth | 0.84 X | ||||
Target Price | 59.12 | ||||
Number Of Employees | 86.09 K | ||||
Beta | 0.45 | ||||
Market Capitalization | 119.06 B | ||||
Total Asset | 126.46 B | ||||
Retained Earnings | 67.5 B | ||||
Working Capital | 6.46 B | ||||
Current Asset | 24.93 B | ||||
Current Liabilities | 16.82 B | ||||
Annual Yield | 0.04 % | ||||
Five Year Return | 3.85 % | ||||
Net Asset | 126.46 B | ||||
Last Dividend Paid | 3.76 |
About Sanofi ADR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sanofi ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanofi ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanofi ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Sanofi ADR Investors Sentiment
The influence of Sanofi ADR's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Sanofi. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Sanofi ADR's public news can be used to forecast risks associated with an investment in Sanofi. The trend in average sentiment can be used to explain how an investor holding Sanofi can time the market purely based on public headlines and social activities around Sanofi ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Sanofi ADR's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Sanofi ADR's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Sanofi ADR's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Sanofi ADR.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sanofi ADR in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sanofi ADR's short interest history, or implied volatility extrapolated from Sanofi ADR options trading.
Currently Active Assets on Macroaxis
When determining whether Sanofi ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanofi ADR's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanofi Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanofi Adr Stock:Check out Sanofi ADR Piotroski F Score and Sanofi ADR Altman Z Score analysis. For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Sanofi Stock analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.217 | Dividend Share 3.76 | Earnings Share 2.29 | Revenue Per Share 18.388 | Quarterly Revenue Growth 0.029 |
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.